Sophie Lanzkron
Elite in Hemolytic Anemia

Dr. Sophie Lanzkron

Hematology
Jefferson Health
Jefferson Hematology - Honickman Center
1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
Accepting New Patients
Elite in Hemolytic Anemia
Jefferson Health
Jefferson Hematology - Honickman Center
1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sophie Lanzkron is a Hematologist in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is currently accepting new patients.

Her clinical research consists of co-authoring 167 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 157 articles and participated in 5 clinical trials in the study of Hemolytic Anemia.

Graduate Institution
Albert Einstein College Of Medicine Of Yeshiva University
Residency
University of Maryland Medical Center
Specialties
Hematology
Licenses
Internal Medicine in MD
Board Certifications
Hematology
Fellowships
Johns Hopkins University School of Medicine
Hospital Affiliations
Thomas Jefferson University Hospital
Jefferson Methodist Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Jefferson Hematology - Honickman Center
1101 Chestnut Street, Floor 8, Philadelphia, PA 19107
Call: 215-955-8435

Additional Areas of Focus

Dr. Lanzkron has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Sickle Cell Disease

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Enrollment Status: Active_not_recruiting
Publish Date: April 29, 2025
Intervention Type: Biological, Other
Study Drug: Red Blood Cell
Study Phase: Phase 3
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
A Phase II, Multicenter, Randomized, Open Label Two Arm Study Evaluating the Effect of Crizanlizumab + Standard of Care and Standard of Care Alone on Renal Function in Sickle Cell Disease Patients ≥ 16 Years With Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Crizanlizuamb
Study Phase: Phase 2
A Phase 1 Randomized, Double-blind, Placebo-controlled, Multicenter, Ascending Dose, Safety and PK/PD Study of SHP655 (rADAMTS13) in Sickle Cell Disease at Baseline Health
A Phase 1 Randomized, Double-blind, Placebo-controlled, Multicenter, Ascending Dose, Safety and PK/PD Study of SHP655 (rADAMTS13) in Sickle Cell Disease at Baseline Health
Enrollment Status: Completed
Publish Date: April 23, 2024
Intervention Type: Other, Drug
Study Drug: SHP655
Study Phase: Phase 1
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drug: Riociguat
Study Phase: Phase 2
A Phase 2 Study of the Safety and Effectiveness of SANGUINATE™ in the Treatment of Vaso-Occlusive Crises in the Ambulatory Setting: A Placebo-Controlled, Single-Dose, Single-Blind Study in Adults With Sickle Cell Disease
A Phase 2 Study of the Safety and Effectiveness of SANGUINATE™ in the Treatment of Vaso-Occlusive Crises in the Ambulatory Setting: A Placebo-Controlled, Single-Dose, Single-Blind Study in Adults With Sickle Cell Disease
Enrollment Status: Completed
Publish Date: May 23, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

167 Total Publications

Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices.
Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices.
Journal: medRxiv : the preprint server for health sciences
Published: November 19, 2025
View All 167 Publications
Similar Doctors
Distinguished in Hemolytic Anemia
Dr. Stella Chou
Hematology | Oncology
Distinguished in Hemolytic Anemia
Dr. Stella Chou
Hematology | Oncology

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (1.9 miles away)
215-590-3535
Languages Spoken:
English
See accepted insurances

Stella Chou is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Chou is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Acute Megakaryoblastic Leukemia, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

Advanced in Hemolytic Anemia
Dr. Farzana A. Sayani
Hematology | Hematology Oncology
Advanced in Hemolytic Anemia
Dr. Farzana A. Sayani
Hematology | Hematology Oncology
3400 Spruce St, 3 Dulles, 
Philadelphia, PA 
 (1.8 miles away)
215-615-5858
Languages Spoken:
English
See accepted insurances

Farzana Sayani is a Hematologist and a Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Sayani is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Thalassemia, Beta Thalassemia, and Hemoglobin SC Disease.

Advanced in Hemolytic Anemia
Dr. Kandace L. Gollomp
Pediatrics | Hematology | Oncology
Advanced in Hemolytic Anemia
Dr. Kandace L. Gollomp
Pediatrics | Hematology | Oncology
34th St. & Civic Center Blvd, The Children's Hospital Of Philadelphia, Room 9nw55, 
Philadelphia, PA 
 (1.9 miles away)
215-590-2437
Languages Spoken:
English
See accepted insurances

Kandace Gollomp is a Pediatrics specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Gollomp is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Alpha Thalassemia, Fetal Edema, Hydrops Fetalis, Vitrectomy, and Bone Marrow Transplant.

VIEW MORE HEMOLYTIC ANEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lanzkron's expertise for a condition
ConditionClose
  • Elite
  • Anemia
    Dr. Lanzkron is
    Elite
    . Learn about Anemia.
    See more Anemia experts
  • Congenital Hemolytic Anemia
    Dr. Lanzkron is
    Elite
    . Learn about Congenital Hemolytic Anemia.
    See more Congenital Hemolytic Anemia experts
  • Hemoglobinopathy
    Dr. Lanzkron is
    Elite
    . Learn about Hemoglobinopathy.
    See more Hemoglobinopathy experts
  • Hemolytic Anemia
    Dr. Lanzkron is
    Elite
    . Learn about Hemolytic Anemia.
    See more Hemolytic Anemia experts
  • Sickle Cell Disease
    Dr. Lanzkron is
    Elite
    . Learn about Sickle Cell Disease.
    See more Sickle Cell Disease experts
  • Distinguished
  • Hemoglobin C Disease
    Dr. Lanzkron is
    Distinguished
    . Learn about Hemoglobin C Disease.
    See more Hemoglobin C Disease experts
  • Hemoglobin E Disease
    Dr. Lanzkron is
    Distinguished
    . Learn about Hemoglobin E Disease.
    See more Hemoglobin E Disease experts
  • Hemoglobin SC Disease
    Dr. Lanzkron is
    Distinguished
    . Learn about Hemoglobin SC Disease.
    See more Hemoglobin SC Disease experts
  • Advanced
  • Beta Thalassemia
    Dr. Lanzkron is
    Advanced
    . Learn about Beta Thalassemia.
    See more Beta Thalassemia experts
  • Thalassemia
    Dr. Lanzkron is
    Advanced
    . Learn about Thalassemia.
    See more Thalassemia experts
  • Thrombotic Thrombocytopenic Purpura
    Dr. Lanzkron is
    Advanced
    . Learn about Thrombotic Thrombocytopenic Purpura.
    See more Thrombotic Thrombocytopenic Purpura experts
  • Experienced
  • Bernard-Soulier Syndrome
    Dr. Lanzkron is
    Experienced
    . Learn about Bernard-Soulier Syndrome.
    See more Bernard-Soulier Syndrome experts
  • Deep Vein Thrombosis
    Dr. Lanzkron is
    Experienced
    . Learn about Deep Vein Thrombosis.
    See more Deep Vein Thrombosis experts
  • Glanzmann Thrombasthenia
    Dr. Lanzkron is
    Experienced
    . Learn about Glanzmann Thrombasthenia.
    See more Glanzmann Thrombasthenia experts
  • Gray Platelet Syndrome
    Dr. Lanzkron is
    Experienced
    . Learn about Gray Platelet Syndrome.
    See more Gray Platelet Syndrome experts
  • Hemolysis
    Dr. Lanzkron is
    Experienced
    . Learn about Hemolysis.
    See more Hemolysis experts
  • Hemolytic Transfusion Reaction
    Dr. Lanzkron is
    Experienced
    . Learn about Hemolytic Transfusion Reaction.
    See more Hemolytic Transfusion Reaction experts
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.